50-198-0942
Dopamine Receptor D1 Rabbit anti-Human, Polyclonal, Bioss
Manufacturer: Bioss
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-198-0942-Each-of-1 | In Stock | ₹ 36,897.75 |
50-198-0942 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,897.75
GST (18%): ₹ 6,641.595
Total Price: ₹ 43,539.345
Antigen
Dopamine Receptor D1
Classification
Polyclonal
Conjugate
Unconjugated
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Human
Product Type
Antibody
Isotype
IgG
Applications
Flow Cytometry, Western Blot
Concentration
1 μg/mL
Formulation
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen
KLH conjugated synthetic peptide derived from human Dopamine Receptor D1.
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
-20°C
Form
Liquid
Related Products
Description
- Dopamine receptor D1 has been reported mostly in various regions of the brain
- ESTs have been isolated from normal olfactory epithelium and cancerous genitourinary tract libraries
- G-protein Coupled Receptors (GPCRs) comprise one of the largest families of signaling molecules with more thana thousandmembers currently predicted to exist
- All GPCRs share a structural motif consisting of seven membrane-spanning helices, and exist in both active and inactive forms
- An array of activating ligands participate in the conformation of GPCRs which leads to signaling via G-proteins and downstream effectors
- Ongoing studies have also shown the vast series of reactions which participate in the negative regulation of GPCRs
- This 'turn-off' activity has tremendous implications for the physiological action of the cell, and continues to drive pharmacological research for new drug candidates
- Twoblockbuster drugs which have been developed as GPCR-targetedpharmaceuticals are Zyprexa (Eli Lilly) and Claritin (Schering-Plough) which have multi-billion dollar shares of the mental health and allergy markets, respectively.
Compare Similar Items
Show Difference
Antigen: Dopamine Receptor D1
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Flow Cytometry, Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human Dopamine Receptor D1.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
Dopamine Receptor D1
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Flow Cytometry, Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human Dopamine Receptor D1.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: ADRA2
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human ADRA2.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
ADRA2
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human ADRA2.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: CYT19
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human CYT19.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
CYT19
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human CYT19.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: IL-12 beta
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: __
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
IL-12 beta
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
__
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid